Skip to main content
Premium Trial:

Request an Annual Quote

Geneva Bioinformatics Hires Infocom to Sell SIB Tools in Japan

NEW YORK, Sept. 24 - Geneva Bioinformatics today said it has tapped Infocom to distribute its SIB database in Japan.


The SIB database includes the Swiss Institute of Bioinformatics' Swiss-Prot, Prosite, and Swiss-2DPage technologies. According to GeneBio, which has had exclusive rights since 1998 to sell technology developed at the SIB, has "collaborated" with Infocom for the past three years.


Click here for more information.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.